Vanina de Verneuil is CLO & VP +1 at Vir Biotechnology, Inc. (VIR). They have made 5 open-market trades across 1 company since 2024, most recently 2026-11-03.
CIK 0002036234
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VIR | 110,193 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2026-11-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VIR | SELL · 10b5-1 | 2026-11-02 | 2026-11-04 | $11.18 | $42K | — | — | — |
| VIR | SELL | 2026-02-24 | 2026-02-26 | $9.77 | $164K | +6.4% | -8.9% | -2.2% |
| VIR | SELL | 2026-02-23 | 2026-02-24 | $7.45 | $33K | -2.7% | -8.8% | -4.4% |
| VIR | SELL · 10b5-1 | 2025-11-05 | 2025-11-07 | $5.16 | $12K | +2.6% | +24.2% | +30.6% |
| VIR | SELL | 2025-11-03 | 2025-11-04 | $5.86 | $8K | +9.1% | +31.4% | +49.4% |
| VIR | SELL · 10b5-1 | 2025-02-26 | 2025-02-27 | $9.14 | $135K | -9.4% | -20.0% | -41.2% |
| VIR | SELL | 2025-02-24 | 2025-02-25 | $9.45 | $49K | -11.8% | -26.1% | -48.4% |
| VIR | SELL | 2024-12-02 | 2024-12-04 | $8.22 | $625 | -8.9% | -9.6% | -1.2% |
| VIR | SELL · 10b5-1 | 2024-11-06 | 2024-11-07 | $10.11 | $44K | -28.6% | -10.1% | +3.6% |
| VIR | SELL · 10b5-1 | 2024-11-01 | 2024-11-05 | $8.62 | $32K | -18.3% | -18.7% | +1.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.